Publications by authors named "R Rozich"

We have previously described the generation of a monoclonal antibody recognizing a novel cholangiocyte marker, designated BD.1, that is expressed by fetal and adult rat cholangiocytes but not hepatocytes or the hepatic progenitor cells known as oval cells. In the present report, we have undertaken a comprehensive examination of BD.

View Article and Find Full Text PDF
Article Synopsis
  • Cholangiocarcinoma, a deadly biliary cancer, often remains undiagnosed until advanced stages, thus highlighting the need to understand its molecular changes for better diagnostic and therapeutic strategies.
  • Researchers observed that rat bile duct epithelial cells (BDEC) showed significant neoplastic traits after extended culture, such as rapid growth, loss of cell adhesion, and changes in cell markers, particularly after reaching high passage numbers (over 85).
  • Sub-lines of high passage BDEC exhibiting activated ErbB-2/Neu led to the formation of tumors in mice, indicating that these cultured cells could serve as models for studying the early stages of cholangiocarcinogenesis and offer insights into potential therapeutic targets.
View Article and Find Full Text PDF

Background & Aims: Cholangiocarcinomas appear to arise from the malignant transformation of cholangiocytes lining the biliary tract. Because the development of an in vitro model of malignant transformation can provide a powerful new tool for establishing critical events governing the molecular pathogenesis of cholangiocarcinoma, we investigated the potential of achieving malignant transformation of cultured rat cholangiocytes in relation to aberrant overexpression of mutationally activated erbB-2/neu.

Methods: Malignant neoplastic transformation was achieved after infection of the rat cholangiocyte cell line, designated BDE1, with the retrovirus Glu664-neu, containing the transforming rat erbB-2/neu oncogene.

View Article and Find Full Text PDF

Long QT syndrome (LQTS) is the prototype of the cardiac ion channelopathies which cause syncope and sudden death. LQT1, due to mutations of KCNQ1 (KVLQT1), is the most common form. This study describes the genotype-phenotype characteristics in 10 families with mutations of KCNQ1, including 5 novel mutations.

View Article and Find Full Text PDF

Cardiac arrhythmias cause 400 000 sudden deaths annually in the United States alone. Mutations in the cardiac sodium channel gene SCN5A on chromosome 3p21 cause cardiac arrhythmias and sudden death. In this study, we define an SCN5A mutation, S1103Y, in a white family associated with syncope, ventricular fibrillation, and sudden death.

View Article and Find Full Text PDF